23andMe moves into clinical trial recruitment
Consumer genetics giant 23andMe is doing a lot more than DNA testing these days.
The Silicon Valley company announced Thursday that it is partnering with TrialSpark, a tech-powered contract research organization, to move much deeper into the business of clinical trial recruitment. What does that mean? In short: Using the data 23andMe collects to connect customers with nearby study sites based on their diseases, demographics, and DNA.
Although the company was tightlipped about details of the arrangement, STAT's Rebecca Robbins reports, it may stand to make some serious money by charging drug makers to serve up information about clinical trials they're sponsoring.
Read more.
The Silicon Valley company announced Thursday that it is partnering with TrialSpark, a tech-powered contract research organization, to move much deeper into the business of clinical trial recruitment. What does that mean? In short: Using the data 23andMe collects to connect customers with nearby study sites based on their diseases, demographics, and DNA.
Although the company was tightlipped about details of the arrangement, STAT's Rebecca Robbins reports, it may stand to make some serious money by charging drug makers to serve up information about clinical trials they're sponsoring.
Read more.
No hay comentarios:
Publicar un comentario